CD68 and neoplasm: Previous studies had reported that RRX-001 exhibits potent anti-cancer activity on tumors dependent on the presence of tumor-associated macrophages in tumor tissue [37, 38], so we assessed the macrophages indicated by CD68 in GCTs treated before and after RRX-001.